Assembly Biosciences, Inc. (ASMB)
22.19
-0.31
(-1.38%)
USD |
NASDAQ |
Nov 20, 16:00
22.26
+0.07
(+0.32%)
After-Hours: 20:00
Assembly Biosciences Total Assets (Quarterly) : 325.29M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 325.29M |
| June 30, 2026 | 330.83M |
| March 31, 2026 | 235.51M |
| December 31, 2025 | 258.29M |
| September 30, 2025 | 240.00M |
| June 30, 2025 | 80.78M |
| March 31, 2025 | 99.02M |
| December 31, 2024 | 119.97M |
| September 30, 2024 | 100.26M |
| June 30, 2024 | 115.32M |
| March 31, 2024 | 119.88M |
| December 31, 2023 | 137.47M |
| September 30, 2023 | 51.63M |
| June 30, 2023 | 66.58M |
| March 31, 2023 | 83.12M |
| December 31, 2022 | 102.60M |
| September 30, 2022 | 121.52M |
| June 30, 2022 | 143.45M |
| March 31, 2022 | 162.73M |
| December 31, 2021 | 192.60M |
| September 30, 2021 | 248.97M |
| June 30, 2021 | 262.14M |
| March 31, 2021 | 278.90M |
| December 31, 2020 | 290.51M |
| September 30, 2020 | 306.31M |
| Date | Value |
|---|---|
| June 30, 2020 | 294.80M |
| March 31, 2020 | 313.31M |
| December 31, 2019 | 347.89M |
| September 30, 2019 | 223.34M |
| June 30, 2019 | 241.51M |
| March 31, 2019 | 259.25M |
| December 31, 2018 | 268.04M |
| September 30, 2018 | 282.98M |
| June 30, 2018 | 142.42M |
| March 31, 2018 | 156.02M |
| December 31, 2017 | 169.30M |
| September 30, 2017 | 112.31M |
| June 30, 2017 | 122.77M |
| March 31, 2017 | 134.28M |
| December 31, 2016 | 98.12M |
| September 30, 2016 | 109.13M |
| June 30, 2016 | 117.21M |
| March 31, 2016 | 124.45M |
| December 31, 2015 | 133.74M |
| September 30, 2015 | 139.65M |
| June 30, 2015 | 144.71M |
| March 31, 2015 | 138.35M |
| December 31, 2014 | 71.23M |
| September 30, 2014 | 60.39M |
| June 30, 2014 | 21.76M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 51.41B |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 26.49M |
| Shareholders Equity (Quarterly) | 298.79M |
| Debt to Equity Ratio | 0.0074 |
| Current Ratio | 12.89 |
| Net Debt Paydown Yield | 0.03% |